- Home
- PACS vs ONTO Comparison
PACS vs ONTO Comparison
Compare PACS & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PACS | ONTO |
|---|---|---|
| Founded | 2013 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 10.9B |
| IPO Year | 2024 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PACS | ONTO |
|---|---|---|
| Price | $34.67 | $189.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $45.50 | ★ $229.38 |
| AVG Volume (30 Days) | ★ 898.3K | 862.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 221.05 | N/A |
| EPS | 1.22 | ★ 2.78 |
| Revenue | ★ $5,288,932,000.00 | N/A |
| Revenue This Year | $10.04 | $26.63 |
| Revenue Next Year | $9.30 | $16.26 |
| P/E Ratio | ★ $27.67 | $66.18 |
| Revenue Growth | ★ 29.32 | N/A |
| 52 Week Low | $7.50 | $89.40 |
| 52 Week High | $43.08 | $232.49 |
Technical Indicators
Market Signals| Indicator | PACS | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 42.61 |
| Support Level | $33.11 | $178.40 |
| Resistance Level | $35.10 | $229.81 |
| Average True Range (ATR) | 1.79 | 10.36 |
| MACD | -0.50 | -3.59 |
| Stochastic Oscillator | 15.98 | 25.80 |
Price Performance
Historical ComparisonAbout PACS PACS Group Inc.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.